Literature DB >> 35639275

Subcutaneous and Transvenous ICDs: an Update on Contemporary Questions and Controversies.

Daniel J Friedman1, Albert S Tully2, Emily P Zeitler2,3.   

Abstract

PURPOSE OF REVIEW: While the subcutaneous (S-) implantable cardioverter-defibrillator (ICDs) is an alternative to the transvenous (TV-) ICD in many patients, optimal use remains unclear. In this review, we summarize recent clinically relevant data on sensing algorithms, inappropriate shocks, defibrillation testing, and battery and electrode failures. RECENT
FINDINGS: Changes in sensing algorithms and S-ICD programming have significantly decreased inappropriate shock rates. Avoiding fat below the S-ICD coil and can is key for reducing the defibrillation threshold. While S-ICD battery and electrode failures have resulted in recalls, system components remain commercially available since failure rates are low and no other similar devices are available. The S-ICD is a good alternative to the TV-ICD for many patients, and particularly in light of recently developed device algorithms and improvements in implant technique. Future research will need to better understand: the impact of S-ICD electrode and battery failures and the potential for integrating leadless pacing into a modular S-ICD platform.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Inappropriate shocks; Subcutaneous implantable cardioverter defibrillator; Sudden cardiac death; Transvenous implantable cardioverter defibrillator

Mesh:

Year:  2022        PMID: 35639275     DOI: 10.1007/s11886-022-01712-6

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   3.955


  30 in total

1.  An entirely subcutaneous implantable cardioverter-defibrillator.

Authors:  Gust H Bardy; Warren M Smith; Margaret A Hood; Ian G Crozier; Iain C Melton; Luc Jordaens; Dominic Theuns; Robert E Park; David J Wright; Derek T Connelly; Simon P Fynn; Francis D Murgatroyd; Johannes Sperzel; Jörg Neuzner; Stefan G Spitzer; Andrey V Ardashev; Amo Oduro; Lucas Boersma; Alexander H Maass; Isabelle C Van Gelder; Arthur A Wilde; Pascal F van Dessel; Reinoud E Knops; Craig S Barr; Pierpaolo Lupo; Riccardo Cappato; Andrew A Grace
Journal:  N Engl J Med       Date:  2010-05-12       Impact factor: 91.245

2.  Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.

Authors:  Martin C Burke; Michael R Gold; Bradley P Knight; Craig S Barr; Dominic A M J Theuns; Lucas V A Boersma; Reinoud E Knops; Raul Weiss; Angel R Leon; John M Herre; Michael Husby; Kenneth M Stein; Pier D Lambiase
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

3.  A new algorithm to reduce inappropriate therapy in the S-ICD system.

Authors:  Amy J Brisben; Martin C Burke; Bradley P Knight; Stephen J Hahn; Keith L Herrmann; Venugopal Allavatam; Deepa Mahajan; Rick Sanghera; Michael R Gold
Journal:  J Cardiovasc Electrophysiol       Date:  2015-02-17

4.  Trends and In-Hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United States.

Authors:  Daniel J Friedman; Craig S Parzynski; Paul D Varosy; Jordan M Prutkin; Kristen K Patton; Ali Mithani; Andrea M Russo; Jeptha P Curtis; Sana M Al-Khatib
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

5.  Intermuscular Two-Incision Technique for Subcutaneous Implantable Cardioverter Defibrillator Implantation: Results from a Multicenter Registry.

Authors:  Federico Migliore; Giuseppe Allocca; Vittorio Calzolari; Martino Crosato; Domenico Facchin; Elisabetta Daleffe; Massimo Zecchin; Mauro Fantinel; Sergio Cannas; Rocco Arancio; Procolo Marchese; Francesco Zanon; Alessandro Zorzi; Sabino Iliceto; Emanuele Bertaglia
Journal:  Pacing Clin Electrophysiol       Date:  2017-02-10       Impact factor: 1.976

6.  Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.

Authors:  Patrick H Pun; Craig S Parzynski; Daniel J Friedman; Gillian Sanders; Jeptha P Curtis; Sana M Al-Khatib
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-23       Impact factor: 8.237

7.  Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.

Authors:  Lucas Boersma; Martin C Burke; Petr Neuzil; Pier Lambiase; Ted Friehling; Dominic A Theuns; Fermin Garcia; Nathan Carter; Timothy Stivland; Raul Weiss
Journal:  Heart Rhythm       Date:  2015-09-01       Impact factor: 6.343

8.  Reduction in inappropriate therapy and mortality through ICD programming.

Authors:  Arthur J Moss; Claudio Schuger; Christopher A Beck; Mary W Brown; David S Cannom; James P Daubert; N A Mark Estes; Henry Greenberg; W Jackson Hall; David T Huang; Josef Kautzner; Helmut Klein; Scott McNitt; Brian Olshansky; Morio Shoda; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2012-11-06       Impact factor: 91.245

9.  Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry.

Authors:  Pier D Lambiase; Craig Barr; Dominic A M J Theuns; Reinoud Knops; Petr Neuzil; Jens Brock Johansen; Margaret Hood; Susanne Pedersen; Stefan Kääb; Francis Murgatroyd; Helen L Reeve; Nathan Carter; Lucas Boersma
Journal:  Eur Heart J       Date:  2014-03-26       Impact factor: 29.983

10.  Real-world performance of the atrial fibrillation monitor in patients with a subcutaneous ICD.

Authors:  Sarah W E Baalman; Suneet Mittal; Lucas V A Boersma; Dave Perschbacher; Amy J Brisben; Deepa Mahajan; Joris R de Groot; Reinoud E Knops
Journal:  Pacing Clin Electrophysiol       Date:  2020-08-07       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.